172 related articles for article (PubMed ID: 18053050)
1. A randomized pilot study comparing the action halos of two commercial preparations of botulinum toxin type A.
Hexsel D; Dal'Forno T; Hexsel C; Do Prado DZ; Lima MM
Dermatol Surg; 2008 Jan; 34(1):52-9. PubMed ID: 18053050
[TBL] [Abstract][Full Text] [Related]
2. Field effect of two commercial preparations of botulinum toxin type A: a prospective, double-blind, randomized clinical trial.
Hexsel D; Brum C; do Prado DZ; Soirefmann M; Rotta FT; Dal'Forno T; Rodrigues TC
J Am Acad Dermatol; 2012 Aug; 67(2):226-32. PubMed ID: 22041253
[TBL] [Abstract][Full Text] [Related]
3. Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis.
Trindade de Almeida AR; Marques E; de Almeida J; Cunha T; Boraso R
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S37-43. PubMed ID: 17241413
[TBL] [Abstract][Full Text] [Related]
4. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
Grosse J; Kramer G; Jakse G
BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
[TBL] [Abstract][Full Text] [Related]
5. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
Farahvash MR; Arad S
J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
8. Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study.
Cliff SH; Judodihardjo H; Eltringham E
J Cosmet Dermatol; 2008 Mar; 7(1):50-4. PubMed ID: 18254812
[TBL] [Abstract][Full Text] [Related]
9. Equipotent concentrations of Botox and Dysport in the treatment of palmar hyperhidrosis.
Rystedt A; Swartling C; Färnstrand C; Naver H
Acta Derm Venereol; 2008; 88(5):458-61. PubMed ID: 18779882
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic properties of different formulations of botulinum neurotoxin type A.
Wohlfarth K; Kampe K; Bigalke H
Mov Disord; 2004 Mar; 19 Suppl 8():S65-7. PubMed ID: 15027057
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacology of botulinum neurotoxin type A].
Bigalke H
Wien Klin Wochenschr; 2001; 113 Suppl 4():2-5. PubMed ID: 15506044
[TBL] [Abstract][Full Text] [Related]
12. Effect of volume and concentration on the diffusion of botulinum exotoxin A.
Hsu TS; Dover JS; Arndt KA
Arch Dermatol; 2004 Nov; 140(11):1351-4. PubMed ID: 15545544
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, comparative study of two type A botulinum toxins in the treatment of primary axillary hyperhidrosis.
Talarico-Filho S; Mendonça DO Nascimento M; Sperandeo DE Macedo F; DE Sanctis Pecora C
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S44-50. PubMed ID: 17241414
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.
Smuts JA; Schultz D; Barnard A
Headache; 2004 Sep; 44(8):801-5. PubMed ID: 15330827
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of therapeutic botulinum toxin preparations.
Dressler D; Benecke R
Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
[TBL] [Abstract][Full Text] [Related]
16. Practical applications of a new botulinum toxin.
Hexsel D; Spencer JM; Woolery-Lloyd H; Gilbert E
J Drugs Dermatol; 2010 Mar; 9(3 Suppl):s31-7. PubMed ID: 20361474
[TBL] [Abstract][Full Text] [Related]
17. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
Hantash BM; Gladstone HB
Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose.
Monheit G; Carruthers A; Brandt F; Rand R
Dermatol Surg; 2007 Jan; 33(1 Spec No.):S51-9. PubMed ID: 17241415
[TBL] [Abstract][Full Text] [Related]
19. Respective potencies of Botox and Dysport in a human skin model: a randomized, double-blind study.
Kranz G; Haubenberger D; Voller B; Posch M; Schnider P; Auff E; Sycha T
Mov Disord; 2009 Jan; 24(2):231-6. PubMed ID: 18951439
[TBL] [Abstract][Full Text] [Related]
20. Safe botulinum toxin type A injection in patients with history of eyelid ptosis.
Ghalamkarpour F; Aghazadeh Y; Odabaei G
J Cosmet Dermatol; 2009 Jun; 8(2):98-102. PubMed ID: 19527332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
